NTGN - Neon Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 569.82M
Enterprise Value 317.16M
Trailing P/E N/A
Forward P/E 1-1.07
PEG Ratio (5 yr expected) 1-0.04
Price/Sales (ttm)N/A
Price/Book (mrq)1.12
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.20

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-78.47%
S&P500 52-Week Change 30.90%
52 Week High 312.6900
52 Week Low 32.2300
50-Day Moving Average 33.2574
200-Day Moving Average 34.9458

Share Statistics

Avg Vol (3 month) 3190.17k
Avg Vol (10 day) 3124.04k
Shares Outstanding 528.33M
Float 15.55M
% Held by Insiders 117.19%
% Held by Institutions 170.35%
Shares Short (Jul 31, 2019) 4600.56k
Short Ratio (Jul 31, 2019) 42.21
Short % of Float (Jul 31, 2019) 44.14%
Short % of Shares Outstanding (Jul 31, 2019) 42.12%
Shares Short (prior month Jun 28, 2019) 4580.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-47.85%
Return on Equity (ttm)-83.86%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -85.72M
Net Income Avi to Common (ttm)-84.47M
Diluted EPS (ttm)-3.0530
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)61M
Total Cash Per Share (mrq)2.15
Total Debt (mrq)8.34M
Total Debt/Equity (mrq)13.40
Current Ratio (mrq)6.13
Book Value Per Share (mrq)2.19

Cash Flow Statement

Operating Cash Flow (ttm)-75.11M
Levered Free Cash Flow (ttm)-48.04M